Medtronic (MDT) Tops Q1 EPS by 9c, Raises EPS Guidance

Medtronic (NYSE: MDT) reported Q1 EPS of $1.41, $0.09 better than the analyst estimate of $1.32. Revenue for the quarter came in at $7.99 billion versus the consensus estimate of $7.85 billion.

GUIDANCE:

Medtronic sees FY2022 EPS of $5.65-$5.75, versus the consensus of $5.69.

• company continues to expect revenue growth in its fiscal year 2022 to approximate 9% on an organic basis

For earnings history and earnings-related data on Medtronic (MDT) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c